1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT analog results in increased expression of CASP8AP2 mRNA CTD PMID:22937105 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o more ... CTD PMID:22937105 1,2-dimethylhydrazine decreases expression ISO RGD:1314006 6480464 1, 2-Dimethylhydrazine results in decreased expression of CASP8AP2 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:1314005 6480464 Dinitrochlorobenzene binds to CASP8AP2 protein CTD PMID:32991956 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:1314006 6480464 2 more ... CTD PMID:24680724 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1314005 6480464 2 more ... CTD PMID:27589474 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314006 6480464 Tetrachlorodibenzodioxin results in decreased expression of CASP8AP2 mRNA CTD PMID:18691609 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CASP8AP2 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314006 6480464 Tetrachlorodibenzodioxin affects the expression of CASP8AP2 mRNA CTD PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CASP8AP2 mRNA CTD PMID:19520675 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1314006 6480464 Tetrachlorodibenzodioxin results in increased expression of CASP8AP2 mRNA CTD PMID:19465110 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CASP8AP2 mRNA CTD PMID:21346803 4,4'-sulfonyldiphenol increases expression ISO RGD:1314006 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CASP8AP2 mRNA CTD PMID:33297965 8'-apo-beta,psi-caroten-8'-al increases expression ISO RGD:1314005 6480464 apocarotenal results in increased expression of CASP8AP2 mRNA CTD PMID:17034753 aflatoxin B1 increases expression ISO RGD:1314006 6480464 Aflatoxin B1 results in increased expression of CASP8AP2 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1314005 6480464 Aflatoxin B1 results in increased methylation of CASP8AP2 intron CTD PMID:30157460 aflatoxin M1 decreases expression ISO RGD:1314005 6480464 Aflatoxin M1 results in decreased expression of CASP8AP2 mRNA CTD PMID:30928695 aristolochic acid A decreases expression ISO RGD:1314005 6480464 aristolochic acid I results in decreased expression of CASP8AP2 mRNA CTD PMID:33212167 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CASP8AP2 mRNA CTD PMID:19730151 arsenous acid multiple interactions ISO RGD:1314005 6480464 Arsenic Trioxide results in increased localization of [CASP8AP2 protein co-treated with PML protein], Arsenic Trioxide results in increased localization of and results in increased degradation of CASP8AP2 protein CTD PMID:23673342 atrazine decreases expression ISO RGD:1314005 6480464 Atrazine results in decreased expression of CASP8AP2 mRNA CTD PMID:22378314 benzatropine multiple interactions ISO RGD:1314005 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of CASP8AP2 protein CTD PMID:34122009 benzo[a]pyrene affects methylation ISO RGD:1314005 6480464 Benzo(a)pyrene affects the methylation of CASP8AP2 intron CTD PMID:30157460 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1314005 6480464 7 more ... CTD PMID:20382639 bis(2-chloroethyl) sulfide increases expression ISO RGD:1314006 6480464 Mustard Gas results in increased expression of CASP8AP2 mRNA CTD PMID:15674844 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CASP8AP2 mRNA CTD PMID:25181051 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of CASP8AP2 mRNA CTD PMID:19167457 cadmium dichloride decreases expression ISO RGD:1314006 6480464 Cadmium Chloride results in decreased expression of CASP8AP2 mRNA CTD PMID:24982889 caffeine decreases phosphorylation ISO RGD:1314005 6480464 Caffeine results in decreased phosphorylation of CASP8AP2 protein CTD PMID:35688186 cannabidiol decreases expression ISO RGD:1314005 6480464 Cannabidiol results in decreased expression of CASP8AP2 mRNA CTD PMID:33244087 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of CASP8AP2 mRNA CTD PMID:23125180 cisplatin increases expression ISO RGD:1314005 6480464 Cisplatin results in increased expression of CASP8AP2 mRNA CTD PMID:27594783 copper(II) sulfate decreases expression ISO RGD:1314005 6480464 Copper Sulfate results in decreased expression of CASP8AP2 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:1314005 6480464 coumarin results in decreased phosphorylation of CASP8AP2 protein CTD PMID:35688186 coumestrol multiple interactions ISO RGD:1314005 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA CTD PMID:19167446 Cuprizon multiple interactions ISO RGD:1314005 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of CASP8AP2 protein CTD PMID:34122009 daidzein multiple interactions ISO RGD:1314005 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 daidzein 7-O-beta-D-glucoside multiple interactions ISO RGD:1314005 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 DDE increases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CASP8AP2 mRNA CTD PMID:24576310 dexamethasone decreases expression ISO RGD:1314006 6480464 Dexamethasone results in decreased expression of CASP8AP2 mRNA CTD PMID:21041162 diarsenic trioxide multiple interactions ISO RGD:1314005 6480464 Arsenic Trioxide results in increased localization of [CASP8AP2 protein co-treated with PML protein], Arsenic Trioxide results in increased localization of and results in increased degradation of CASP8AP2 protein CTD PMID:23673342 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of CASP8AP2 mRNA CTD PMID:19730151 diazinon affects expression EXP 6480464 Diazinon affects the expression of CASP8AP2 mRNA CTD PMID:22546817 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of CASP8AP2 mRNA CTD PMID:22546817 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of CASP8AP2 mRNA CTD PMID:26476374 dioxygen multiple interactions EXP 6480464 Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8AP2 mRNA] CTD PMID:26476374 doxorubicin decreases expression ISO RGD:1314005 6480464 Doxorubicin results in decreased expression of CASP8AP2 mRNA CTD PMID:29803840 folic acid decreases expression ISO RGD:1314006 6480464 Folic Acid results in decreased expression of CASP8AP2 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO RGD:1314005 6480464 Formaldehyde results in decreased expression of CASP8AP2 mRNA CTD PMID:20655997 furan increases expression EXP 6480464 furan results in increased expression of CASP8AP2 mRNA CTD PMID:22079235 genistein increases expression ISO RGD:1314005 6480464 Genistein results in increased expression of CASP8AP2 mRNA CTD PMID:15256057 genistein multiple interactions ISO RGD:1314005 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 genistein 7-O-beta-D-glucoside multiple interactions ISO RGD:1314005 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CASP8AP2 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CASP8AP2 mRNA CTD PMID:33387578 glycitein multiple interactions ISO RGD:1314005 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 glycitin multiple interactions ISO RGD:1314005 6480464 [daidzein co-treated with daidzin co-treated with genistin co-treated with Genistein co-treated with glycitin co-treated with glycitein] results in increased expression of CASP8AP2 mRNA CTD PMID:27424125 hydrogen peroxide decreases expression ISO RGD:1314005 155663665 hydrogen peroxide decreases expression of CASP8AP2 protein in umbilical vein endothelial cells RGD methotrexate increases response to substance ISO RGD:1314005 6480464 CASP8AP2 mRNA results in increased susceptibility to Methotrexate CTD PMID:22753658 methyl methanesulfonate increases expression ISO RGD:1314005 6480464 Methyl Methanesulfonate results in increased expression of CASP8AP2 mRNA CTD PMID:23649840 Mitotane increases expression EXP 6480464 Mitotane analog results in increased expression of CASP8AP2 mRNA, Mitotane results in increased expression of CASP8AP2 mRNA CTD PMID:23485034 N-nitrosodiethylamine increases expression ISO RGD:1314006 6480464 Diethylnitrosamine results in increased expression of CASP8AP2 mRNA CTD PMID:17854601 N-nitrosodiethylamine multiple interactions ISO RGD:1314006 6480464 RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CASP8AP2 mRNA] CTD PMID:17854601 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CASP8AP2 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of CASP8AP2 mRNA CTD PMID:25729387 p-menthan-3-ol decreases expression ISO RGD:1314005 6480464 Menthol results in decreased expression of CASP8AP2 mRNA CTD PMID:26760959 paracetamol affects expression ISO RGD:1314006 6480464 Acetaminophen affects the expression of CASP8AP2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1314005 6480464 Acetaminophen results in increased expression of CASP8AP2 mRNA CTD PMID:22230336 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1314005 6480464 perfluorooctane sulfonic acid results in decreased expression of CASP8AP2 mRNA CTD PMID:27153767 propylparaben increases expression ISO RGD:1314005 6480464 propylparaben results in increased expression of CASP8AP2 mRNA CTD PMID:24481588 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Oxygen deficiency results in increased expression of CASP8AP2 mRNA] CTD PMID:26476374 resveratrol multiple interactions ISO RGD:1314005 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CASP8AP2 mRNA CTD PMID:19167446 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CASP8AP2 mRNA CTD PMID:25905778 silicon dioxide decreases expression ISO RGD:1314006 6480464 Silicon Dioxide results in decreased expression of CASP8AP2 mRNA CTD PMID:19073995 sodium arsenite increases expression ISO RGD:1314005 6480464 sodium arsenite results in increased expression of CASP8AP2 mRNA CTD PMID:17879257 sodium arsenite decreases expression ISO RGD:1314006 6480464 sodium arsenite results in decreased expression of CASP8AP2 mRNA CTD PMID:16014739 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of CASP8AP2 mRNA CTD PMID:22110744 sodium fluoride increases expression ISO RGD:1314006 6480464 Sodium Fluoride results in increased expression of CASP8AP2 mRNA CTD PMID:27862939 succimer multiple interactions ISO RGD:1314006 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CASP8AP2 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP8AP2 mRNA CTD PMID:21641980 , PMID:26378955 tetrachloromethane increases expression ISO RGD:1314006 6480464 Carbon Tetrachloride results in increased expression of CASP8AP2 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CASP8AP2 mRNA CTD PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CASP8AP2 mRNA CTD PMID:25729387 trimellitic anhydride increases expression ISO RGD:1314006 6480464 trimellitic anhydride results in increased expression of CASP8AP2 mRNA CTD PMID:19042947 triptonide decreases expression ISO RGD:1314006 6480464 triptonide results in decreased expression of CASP8AP2 mRNA CTD PMID:33045310 tungsten decreases expression ISO RGD:1314006 6480464 Tungsten results in decreased expression of CASP8AP2 mRNA CTD PMID:30912803 valproic acid decreases expression ISO RGD:1314005 6480464 Valproic Acid results in decreased expression of CASP8AP2 mRNA CTD PMID:28001369